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T3 is an important regulator of skeletal development and adult bone maintenance. Thyroid hor-
mone action requires efficient transport of T4 and T3 into target cells. We hypothesized that
monocarboxylate transporter (MCT) 8, encoded by Mct8 on the X-chromosome, is an essential
thyroid hormone transporter in bone. To test this hypothesis, we determined the juvenile and adult
skeletal phenotypes of maleMct8 knockout mice (Mct8KO) andMct8D1D2KO compound mutants,
which additionally lack the ability to convert the prohormone T4 to the active hormone T3. Prenatal
skeletal development was normal in both Mct8KO and Mct8D1D2KO mice, whereas postnatal
endochondral ossification and linear growthwere delayed in bothMct8KO andMct8D1D2KOmice.
Furthermore, bone mass and mineralization were decreased in adult Mct8KO and Mct8D1D2KO
mice, and compound mutants also had reduced bone strength. Delayed bone development and
maturation inMct8KO andMct8D1D2KOmice is consistent with decreased thyroid hormone action
in growth plate chondrocytes despite elevated serum T3 concentrations, whereas low bone mass
and osteoporosis reflects increased thyroid hormone action in adult bone due to elevated systemic
T3 levels. These studies identify an essential physiological requirement for MCT8 in chondrocytes,
and demonstrate a role for additional transporters in other skeletal cells during adult bone
maintenance. (Endocrinology 158: 3055–3066, 2017)
Thyroid hormone is an important regulator of skeletaldevelopment, linear growth, and adult bonemass and
strength (1). The prohormone T4 (3,5,30,50-L-tetraiodo-
thyronine, thyroxine) is the most abundant circulating
thyroid hormone, but it must be metabolized to the active
hormone T3 (3,5,30-L-triiodothyronine) for physiological
activity (2). The major effects of T3 in bone are mediated
by thyroid hormone receptor a1, but these actions are
dependent on efficient transport and intracellular me-
tabolism (1). Entry of T4 and T3 into target tissues is
facilitated by cell membrane transporters including the
L-type amino acid transporters 1 and 2, organic anion
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transporter polypeptide-1c1, and monocarboxylate trans-
porters (MCTs) 8 and 10 (3).
The type 1 and 2 iodothyronine deiodinases (DIO1 and
DIO2) convert T4 toT3 by removal of an outer-ring iodine
atom. A third enzyme (DIO3) prevents activation of T4
and inactivates T3 by inner-ring deiodination, generating
the metabolites reverse T3 (3,30,50-triiodothyronine; rT3)
and T2 (3,30-diiodothyronine), respectively (2). DIO1 is
not expressed in the skeleton,whereas the relative activities
of DIO2 and DIO3 determine the intracellular availability
of T3 in target tissues including bone (4, 5). DIO3 is
expressed most abundantly during intrauterine develop-
ment when it protects developing tissues from premature
exposure to T3, whereas levels of DIO2 rise mainly from
birth (1, 2, 6). Expression of DIO2 in the epiphyseal
growth plate regulates T3 availability and the pace of
chondrocyte differentiation during early skeletal devel-
opment (6, 7), and its expression in bone-forming osteo-
blasts controls T3 regulation of adult bone mineralization
and strength (8).
In contrast to the established importance of DIO2 and
DIO3 in the regulation of T3 action in bone, it is not
known which transporters facilitate thyroid hormone
entry into skeletal cells. L-type amino acid transporters 1
and 2 are expressed in the skeleton, but their lack of
response to altered thyroid hormone concentrations, and
their relatively lower affinity and specificity for T4 and
T3, suggest they do not have a major role in control of
T3 action in bone (4, 9, 10). Although organic anion
transporter polypeptide-1c1 is a high-affinity transporter
for T4, it is not expressed in skeletal cells (10). By con-
trast, MCT8 is expressed and regulated by thyroid
hormone in growth plate chondrocytes, bone-forming
osteoblasts, and bone-resorbing osteoclasts (4, 10),
whereasMCT10 is expressed in chondrocytes (9) but has
not been studied in other skeletal cells. Mutations of the
MCT8 gene in humans (OMIM 300523) cause severe
X-linked psychomotor retardation together with high
serumT3, elevated or normal thyrotropin (TSH), decreased
T4, and markedly reduced rT3 concentrations (11–13).
Although linear growth is not significantly impaired in the
majority of cases, bone age has been reported as normal (11,
12, 14), advanced (15), or delayed (16) in individual pa-
tients. Deletion ofMct8 in mice also results in increased T3
and TSH levels and reduced serum T4 and rT3 concen-
trations but fails to recapitulate the psychomotor re-
tardation (17, 18), whereas effects on the skeleton have not
been studied.
We hypothesized that MCT8 is an essential thyroid
hormone transporter required for bone development,
mineralization, and strength. To test this hypothesis,
we determined the skeletal consequences of deletion of
Mct8 inMct82/y knockout (KO) mice (Mct8KO) compared
with wild-type (WT) mice. To investigate the possibility
that other thyroid hormone transporters could contribute
to thyroid hormone uptake, we also compared Mct8KO
mice to triple KOMct82/yDio12/2Dio22/2mice, which are
deprived of the intracellularly generated active T3 as they
lack both thyroid hormone–activating enzymes and Mct8
(Mct8D1D2KO). In these studies, an abnormal skeletal
phenotype in Mct8KO mice would indicate an essential
physiological role for MCT8 in bone. An equivalent phe-
notype inMct8D1D2KOmicewould identifyMCT8as the
sole thyroid hormone transporter in the skeleton, whereas
a more severe skeletal phenotype in Mct8D1D2KO mice
would suggest an additional transporter contributes to
thyroid hormone uptake in bone.
Materials and Methods
Mice
Dio1 KO (Dio12/2, D1KO), Dio2 KO (Dio22/2, D2KO)
and Mct8 KO (Mct82 /y, Mct8KO) mice have been de-
scribed previously and were crossed to obtain Mct8KO,
Mct82/yDio12/2Dio22/2 (Mct8D1D2KO) and WT mice (19).
All KOmice were backcrossed more than 10 times with theWT
C57BL/6 strain. Mice were housed at 22°C 6 2°C with a
12-hour light/12-hour dark cycle, and access to Purina Rodent
Chow (0.8 ppm iodine; Purina Mills, St. Louis, MO) and water
ad libitum. Male mice were collected at postnatal days (P)1,
P14, P32, P77, and P112. Adult mice were given intraperitoneal
injections of calcein (10 mg/kg in 100 mL phosphate-buffered
saline) 14 and 7 days before euthanasia (20).
Ethics
Animal studies were performed according to a protocol
approved following independent review by The University of
Chicago Institutional Animal Care and Use Committee.
Hormone levels
Circulating levels of total T3, T4, rT3, and TSH were
measured by radioimmunoassay in serum samples collected at
P1 (WT, n = 4; Mct8KO, n = 5; Mct8D1D2KO, n = 4), P14
(WT, n = 4;Mct8KO, n = 4;Mct8D1D2KO, n = 4), P32 (WT,
n = 4;Mct8KO, n = 3;Mct8D1D2KO, n = 3), P77 (WT, n = 4;
Mct8KO, n = 4;Mct8D1D2KO, n = 4), and P112 (WT, n = 4;
Mct8KO, n = 5; Mct8D1D2KO, n = 5) as described (21).
Whole mount stains
P1 mice were euthanized, fixed, and stored in 70% ethanol.
Skin and viscera were removed, and the intact skeleton stained
with alizarin red and alcian blue and stored in 100% glycerol
(22). Stained P1 mice were imaged using a Leica MZ75 bin-
ocular microscope, KL1500 light source, DFC320 digital
camera, and IM50Digital ImageManager (LeicaMicrosystems,
Heerbrugg, Switzerland).
RNA isolation and quantitative reverse transcription
polymerase chain reaction
Whole tibias fromWTmice between embryonic day (E) 14.5
(E14.5) and P186 were pulverized at280°C using a steel pestle
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andmortar (Biospec; Thistle Scientific, Glasgow, Scotland, UK),
the resulting powder was homogenized in TRIzol (Thermo
Fisher Scientific, Waltham,MA), and RNAwas extracted (n = 8
per age). Quantitative reverse transcription polymerase chain
reaction (qRT-PCR)was performed using complementaryDNA
synthesized with polyA primers and superscript II reverse
transcription (Thermo Fisher Scientific). A total of 1 mg RNA
was denatured at 70°C for 10 minutes, and polyA primers
and 1 U of superscriptase II were added and incubated for a
further 30 minutes at 42°C. Standard PCR was performed
using Platinum Taq DNA polymerase (Thermo Fisher Sci-
entific) to optimize conditions for quantitative polymerase
chain reaction (qPCR). Expression of Mct8 was determined
by qPCR after RNA quantity and quality was confirmed
using a Nanodrop 1000 spectrophotometer (Thermo Fisher
Scientific). Seven hundred fifty nanograms RNA was con-
verted to complementary DNA using a Quantitect reverse
transcription kit (QIAGEN, Manchester, UK) and used for
qRT-PCR using a KAPA SYBR Fast qPCR kit (KAPA Bio-
systems, London, UK). Reactions were run on a 7900HT
real-time PCR system (Thermo Fisher Scientific) for between
30 and 40 cycles (primers in Table 1). Samples were run in
duplicate and results calculated by comparison with a
standard curve and normalized relative to expression of
Gapdh.
Histology
Lower limbs were fixed in 10% neutral buffered formalin
for 24 hours and decalcified using 10% EDTA pH 7.4. De-
calcification was verified by digital X-ray microradiography
(MX20 Faxitron: Qados, Cross Technologies plc, Sandhurst,
Berkshire, UK). Paraffin-embedded 5-mm sections were stained
with alcian blue and van Gieson (8, 20) and imaged using a
Leica DM LB2 microscope and Leica DFC320 digital camera.
Total growth plate height and growth plate zone measurements
were determined at a minimum of four separate positions using
ImageJ (http://rsb.info-nih.gov/ij/) to determine mean values.
Results from two levels of sectioning were compared (23).
Digital X-ray microradiography
Upper limbs, lower limbs, and tail vertebrae were imaged
using a Faxitron MX20 at 26 kV, and 35 projective magni-
fication giving 10-mm resolution, and bone mineral content
(BMC) relative to steel, aluminum, and polyester standards was
determined. Images were calibrated with a digital micrometer,
and bone length, cortical bone diameter, and thickness were
determined (8, 23, 24).
Microcomputerized tomography
Femurs were imaged in 70% ethanol using a Skyscan 1172a
microcomputerized tomography scanner (Bruker MicroCT,
Kontich, Belgium). Scans were performed at 50 kV, 200 mA,
0.5-mm aluminum filter with a detection pixel size of 4 mm2,
and imageswere reconstructed using SkyscanNRecon software.
Trabecular number (Tb.N), thickness (Tb.Th), bone volume
as a proportion of tissue volume (BV/TV), and structure model
index were calculated within a 1-mm3 region of interest located
0.2 mm below the growth plate (8, 20).
Three-dimensional backscattered electron-scanning
electron microscopy
Femurs and tibia were opened longitudinally and macerated
as described (25). Carbon-coated samples were imaged using
backscattered electrons with a Zeiss DSM962 digital scanning
electron microscope (Carl Zeiss Ltd., Cambridge, UK) at 20 kV
beam potential. The fraction of trabecular and endosteal bone
surfaces displaying osteoclastic resorption were quantified in
high-resolution images using ImageJ (8).
Quantitative backscattered electron-scanning
electron microscopy
Neutral buffered formalin–fixed humeri and tibias were
embedded in methacrylate. Longitudinal block faces were cut
through specimens, which were then polished, coated with
carbon, and analyzed using backscattered electrons at 20 kV,
0.5 nA with a working distance of 17 mm and a sample-to-
detector distance of 11 mm. Bone mineralization densities were
determined by comparison with halogenated dimethacrylate
standards, and an eight-interval pseudocolor scheme was used
to represent the graduations of micromineralization (8, 25, 26).
Static osteoclast histomorphometry
Sections from decalcified tibias were stained for tartrate-
resistant acid phosphatase and imaged using a Leica DM LB2
microscope and DFC320 digital camera (8, 23). A montage of
nine overlapping fields covering an area of 1 mm2 located
0.2 mm below the growth plate was constructed for each bone.
BV/TVwas measured, and osteoclast numbers and surface were
determined in trabecular bone normalized to total bone sur-
face (23).
Dynamic osteoblast histomorphometry
Methacrylate-embedded calcein-labeled tibias were imaged
with a Leica SP2 reflection confocal microscope at 488-nm
excitation. Parameters of bone formation were determined
using ImageJ according to the American Society for Bone and
Mineral Research system of nomenclature (27, 28). The mineral
apposition rate (MAR) was calculated by determining calcein
separation at 20 locations per specimen beginning 0.2 mm
below the growth plate and including both cortical and tra-
becular surfaces. Bone formation rate (BFR) was calculated
Table 1. qRT-PCR Primers
Gene MGI Symbol Accession No. Ensemble Transcript ID Primer Sequence (50–30) Tm, °C Size, bp
Mct8 Mct8 NM_009197.2 ENSMUST00000042664 F: TTGCTTTCATTGGCCTCCA 52 143
(Slc16a2) R: GCGACGTTGAAAGTAGTGGC
Gapdh Gapdh NM_008084 ENSMUST00000073605 F: AACTTTGGCATTGTGGAAGG 54 223
R: ACACATTGGGGGTAGGAACA
Abbreviations: bp, base pair; F, forward; MGI, Mouse Genome Informatics; R, reverse.
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from the product of mineralizing surface (MS) and MAR
(8, 23, 28).
Destructive three-point bend testing
Tibias were stored and tested in 70% ethanol. Mechanical
strength was determined by destructive three-point bend testing
using an Instron 5543 load frame with a 100-N load cell and a
constant rate of displacement of 0.03 mm/s until fracture
(Instron Limited, High Wycombe, Buckinghamshire, UK).
Biomechanical variables were calculated from load displace-
ment curves (8, 29).
Statistical analysis
Data are shown as mean 6 standard deviation unless
otherwise indicated. Normally distributed data were ana-
lyzed by analysis of variance followed by Tukey post hoc test.
P values , 0.05 were considered significant. Frequency
distributions of mineralization densities from quantitative
backscattered electron-scanning electron microscopy (BSE-
SEM) and digital X-ray microradiography images were
compared using the Kolmogorov-Smirnov test (8, 20, 24).
Results
Thyroid dysfunction in Mct8KO and
Mct8D1D2KO mice
Mct8KO mice had decreased T4 and rT3 levels but in-
creased TSH and slightly elevated T3 concentrations com-
paredwithWTmice (Fig. 1), as reported previously (17–19,
30). Consistent with previous data (19), Mct8D1D2KO
mice had elevated T4, rT3, and TSH concentrations at all
ages compared with WT and Mct8KO mice. Serum T3
levels were also elevated inMct8D1D2KO mice compared
with WT but not Mct8KO mice. Overall, Mct8KO mice
have mild central resistance to thyroid hormone with de-
creased T4 concentrations and slightly elevated T3 con-
centrations leading to an increased systemic T3:T4 ratio.
These abnormalities are accompanied by decreased DIO3-
mediated 5-deiodination but increased DIO1- and DIO2-
mediated 50-deiodination (19). By contrast,Mct8D1D2KO
mice have severe central resistance to thyroid hormone with
systemic hyperthyroidism and increased 5-deiodination but
absent 50-deiodination.
Normal prenatal skeletal development in Mct8KO
and Mct8D1D2KO mice
In WT mice, the normal physiological expression of
Mct8 in the skeleton was highest in the prenatal period
but decreased thereafter and remained at a constant level
in juvenile and adult WT mice [Fig. 2(a)]. Formation of
ossification centers in the limbs did not differ between
neonatal WT,Mct8KO, andMct8D1D2KO mice at P1.
Similarly, there were no differences in development of the
skull [Fig. 2(b–d)]. Thus, prenatal endochondral and
intramembranous ossification were normal in bothMct8KO
and Mct8D1D2KO mice.
Figure 1. Serum thyroid hormone levels. (a) Total T4 and (c) rT3
levels in P1, P14, P32, P77, and P112 mice, and (b) total T3 and (d)
TSH in P14, P32, P77, and P112 mice. Data are mean 6 standard
error of the mean; n = 3–5 per genotype per age; *P , 0.05, **P ,
0.01, ***P , 0.001 vs WT; #P , 0.05, ##P , 0.01, ###P , 0.001
vs Mct8KO; analysis of variance followed by Tukey post hoc test.
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Delayed postnatal endochondral ossification and
linear growth in Mct8KO and Mct8D1D2KO mice
Mct8KO andMct8D1D2KOmice had similar degrees
of postnatal growth retardation of long bones and ver-
tebrae between P1 and P77 although long bone length
was increased at P112 [Fig. 2(e)]. Accordingly, X-ray
and histological analysis demonstrated delayed postna-
tal endochondral ossification in both Mct8KO and
Mct8D1D2KO mice characterized by decreased sec-
ondary ossification center size and increased growth plate
height compared with WT (Fig. 3). At P14 the increased
height of the growth plate resulted mainly from an in-
crease in the reserve zone (RZ), which was accompanied
by a small increase in the proliferative zone (PZ) but a
reduction in the hypertrophic zone (HZ). The height of
the growth plate did not differ at P32 in eitherMct8KO or
Mct8D1D2KO mice compared with WT, although mi-
nor differences in the PZ and HZ relative to the total
height of the growth plate were observed. The height of
the growth plates remained increased at P77 and P112 in
both Mct8KO and Mct8D1D2KO mice compared with
WT, although the relative heights of the RZ, PZ, and HZ
were normal.
Overall, these data are consistent with a similar de-
gree of delayed endochondral ossification in Mct8KO
and Mct8D1D2KO mice that results primarily from
impaired recruitment of RZ chondrocyte progenitors to
the PZ at P14 and leads to delayed postnatal growth.
Delayed progression of chondrocytes through the PZ
and HZ chondrocytes continues and persists into
adulthood, resulting in continued linear growth between
P77 and P112. These findings are characteristic of im-
paired T3 action in growth plate chondrocytes and the
response of the developing skeleton to hypothyroid-
ism (1).
Abnormal BMC in Mct8KO and Mct8D1D2KO mice
Long bones fromMct8KO mice had increased BMC
at P14 but decreased BMC at P32. At P77 BMC was
normal, whereas at P112 BMC was decreased. At all
ages, BMC in Mct8D1D2KO mice was decreased
compared with BMC in Mct8KO mice and was de-
creased compared with WT mice at all ages from P32
(Fig. 4).
Figure 2. Skeletal development and linear growth. (a) Mct8 mRNA
expression in whole tibias from WT mice (n = 8 biological replicates
per group, 2 technical replicates per sample); analysis of variance
(ANOVA) , two-sided Tukey post hoc test; ***P , 0.001 vs expression
at P1. (b) Limbs from P1 WT, Mct8KO, and Mct8D1D2KO mice stained
with alizarin red (bone) and alcian blue (cartilage); scale bar = 1 mm.
Figure 2. (Continued). (c) Forelimb digits and cranial vaults stained
with alizarin red and alcian blue; scale bar = 1 mm. (d) Fontanelle
area and cephalic index (cephalic index is calculated by dividing
cranial width by cranial length and then multiplying the result by
100) in P1 skulls, n = 4 per genotype. (e) Ulna lengths and caudal
vertebra heights from birth to P112.Data are mean 6 standard
error of the mean; n = 4 per genotype per age; *P , 0.05,
**P , 0.01, ***P , 0.001 vs WT; ANOVA followed by Tukey
post hoc test.
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Decreased bone mass and mineralization in Mct8KO
and Mct8D1D2KO mice
Microcomputerized tomography analysis of the femur
fromP112mice demonstrated decreased BV/TV and Tb.N
in bothMct8KO andMct8D1D2KOmice,with decreased
Tb.Th and decreased cortical bone volume and thickness
also seen in Mct8D1D2KO mice (Fig. 5). These findings
were confirmed in P77 mice by BSE-SEM [Fig. 6(a)].
Further analysis by quantitative BSE-SEM demonstrated
decreased bone mineralization density in both Mct8KO
andMct8D1D2KOmice, withMct8D1D2KOmicemore
markedly affected [Fig. 6(b)]. Overall, adultMct8KO and
Mct8D1D2KO mice each had decreased bone mass and
mineralization, with a more severe phenotype evident in
Mct8D1D2KO animals.
Increased trabecular bone resorption in
Mct8D1D2KO mice
The underlying cellular basis for the observed defects in
BMCandbonemasswere investigatedby static anddynamic
histomorphometry. Trabecular bone resorption surfaces
were increased in Mct8D1D2KO mice, but all other pa-
rameters of bone resorption [osteoclast number per bone
surface and osteoclast surface per millimeter of bone surface
formation (corticalMS,MAR, andBFR)were similar inWT,
Mct8KO, andMct8D1D2KOmice (Fig. 7). In summary, the
greater decrease in bone mass observed in Mct8D1D2KO
mice resulted from increased osteoclastic bone resorption.
Decreased bone strength in Mct8D1D2KO mice
The consequences of the observed defects in BMC,
mass, and mineralization on bone strength were de-
termined in biomechanical studies. Tibias from adult
Mct8D1D2KOmice were weak with decreased yield and
maximum loads, whereas tibias fromMct8KOmice were
of normal strength (Fig. 8).
Discussion
The skeleton is an important T3-target tissue (Table 2)
(1), and physiological thyroid hormone action requires
efficient transport of T4 and T3 into target cells (3). We
identified an essential role for MCT8 in the skeleton by
analyzing (1) mice that lack Mct8 alone (Mct8KO) and
(2) mice that lack bothMct8 and the ability to convert T4
to the active hormone T3 (Mct8D1D2KO).
Figure 3. Endochondral ossification. (a) Microradiographs of
proximal tibia from P14 WT, Mct8KO, and Mct8D1D2KO mice; scale
bar = 0.5 mm. (b) Decalcified sections of P14 proximal tibia stained
with alcian blue (cartilage) and van Gieson (bone matrix); scale bars
= 0.5 mm. The left graph shows growth plate, RZ, PZ, and HZ
heights. The graph on the right shows relative values, where each
Figure 3. (Continued). zone is shown as a percentage of total
growth plate height. (c–e) Proximal tibia sections from P32, P77,
and P112 mice with graphs showing total and relative growth plate
zone heights. Data are mean 6 standard error of the mean; n = 4 per
genotype; *P , 0.05, **P , 0.01, ***P , 0.001 vs height of zone in
WT; #P , 0.05, ##P , 0.01 vs total growth plate height in WT; analysis
of variance followed by Tukey post hoc test; scale bars = 0.5 mm.
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Skeletal thyroid hormone deficiency and excess in
Mct8KO and Mct8D1D2KO mice
In WT miceMct8 is expressed in the skeleton at high
levels in utero but declines at birth and remains stable
thereafter. During postnatal development, Mct8KO
mice have delayed endochondral ossification and
transient growth retardation accompanied by minor
differences in BMC.AdultMct8KOmice have decreased
bone mass and mineralization, but bones are of normal
strength. This complex phenotype was more severe in
Figure 4. Bone mineral content. Quantitative microradiographic images of long bones from (a) P14, (b) P32, (c) P77, and (d) P112 WT, Mct8KO
and Mct8D1D2KO mice; scale bars = 1 mm. Pseudocolored images represent grayscale images using a 16-color interval scheme with low mineral
content in blue and high mineral content in pink. Relative frequency histograms of BMC (n = 4 per genotype per age). *P , 0.05, **P , 0.01,
***P , 0.001 vs WT, ###P , 0.001 vs Mct8KO; Kolmogorov-Smirnov test.
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Mct8D1D2KO mice, in which adult osteoporosis
resulted in decreased bone strength.
Thyroid hormone exerts anabolic actions during
postnatal skeletal development but elicits catabolic
Figure 6. Bone microarchitecture and micromineralization density.
(a) Low- and higher-power BSE-SEM images of distal femur from
P77 WT, Mct8KO, and Mct8D1D2KO mice. Images are representative
examples of n = 4 per genotype; scale bars = 200 mm. (b) Quantitative
BSE-SEM images of proximal humerus from P77 WT, Mct8KO,
and Mct8D1D2KO mice; scale bars = 200 mm. Grayscale images
were pseudocolored using an eight-color interval scheme with
low mineralization density in blue and high density in pink/white.
White boxes indicate the region of interest used for quantitation
of trabecular bone micromineralization density. Relative frequency
histograms of bone micromineralization densities of proximal humerus
and trabecular bone compartment. Images representative of n = 4
per genotype; ***P , 0.001 vs WT, #P , 0.05 vs Mct8KO, ###P ,
0.001 vs Mct8KO; Kolmogorov-Smirnov test.
Figure 5. Bone structure. (a) Longitudinal midline microcomputerized
tomography–rendered images of distal femur from P112 WT, Mct8KO
and Mct8D1D2KO mice; scale bars = 2 mm. (b) Transverse views
of proximal (upper panels), midshaft (middle panels), and distal
Figure 5. (Continued). (lower panels) femur; scale bars = 2 mm. (c)
Trabecular bone structural parameters: BV/TV, Tb.N, Tb.Th, and
structure model index (SMI). Data are mean 6 standard error of
the mean; n = 4 per genotype; *P , 0.05, **P , 0.01 vs WT;
analysis of variance (ANOVA) followed by Tukey post hoc test.
(d) Cortical bone structural parameters: cortical bone volume and
cortical thickness. Data are mean 6 standard error of the mean;
n = 4 per genotype; *P , 0.05, **P , 0.01 vs WT; ANOVA
followed by Tukey post hoc test.
3062 Leitch et al Role of MCT8 in Bone Endocrinology, September 2017, 158(9):3055–3066
Downloaded from https://academic.oup.com/endo/article-abstract/158/9/3055/3868825
by University of Sheffield user
on 16 January 2018
responses in the adult skeleton (Table 2) (1). Thus, T3
stimulates bone mineral accrual during endochondral
ossification and growth, but increases bone resorption
in adults. In adults with thyrotoxicosis, increased bone
turnover and uncoupling of bone resorption and
formation results in accelerated bone loss, osteoporosis,
and fracture (1). Thus, delayed bone development and
maturation in Mct8KO and Mct8D1D2KO mice is
consistent with skeletal thyroid hormone deficiency,
whereas bone loss and osteoporosis in adults reflects
skeletal thyroid hormone excess. Overall, both Mct8KO
andMct8D1D2KOmice have a mixed phenotype of age-
dependent skeletal thyroid hormone deficiency and excess
that is more severe in Mct8D1D2KO mutants.
Role of circulating and local thyroid status in
Mct8KO mice
Tissue thyroid hormone deficiency during skeletal
development inMct8KOmice occurs despite an elevated
circulating T3 concentration and increased DIO1- and
DIO2-mediated 50-deiodination (19). Thus, tissue thy-
roid hormone deficiency during bone development in
Mct8KO mice reflects impaired thyroid hormone entry
into chondrocytes with an inadequate compensatory
increase in local generation of T3 in the growth plate by
DIO2. This problem appears critical at the time of
maximal postnatal linear growth, which correlates with
the normal peak in circulating thyroid hormone levels
and represents a period of exquisite T3 sensitivity in
growth plate chondrocytes (1, 25).
By contrast, tissue thyroid hormone excess in the
adult skeleton in Mct8KO mice likely results from the
Figure 7. Osteoclastic bone resorption and osteoblastic bone
formation. (a) Three-dimensional BSE-SEM images of trabecular
bone and midfemur endocortical bone surface from femurs of P77
WT, Mct8KO, and Mct8D1D2KO mice (arrows indicate borders
between regions of osteoclastic resorption and unresorbed bone
surfaces, scale bars = 200 mm). Resorption surfaces shown as
percentage of total bone surface in trabecular and cortical bone.
Data are mean 6 standard error of the mean; n = 4 per genotype;
*P , 0.05 vs WT; analysis of variance followed by Tukey post hoc
test. (b) Section from proximal humerus of P77 mice stained with
tartrate-resistant acid phosphatase for osteoclasts in red; scale bar =
200 mm. Number of osteoclasts per millimeter of bone surface
(OcN/BS) and osteoclast surface per millimeter of bone surface (OcS/
BS). (c) Confocal images of humerus cortical bone double-labeled
with calcein from P112 WT, Mct8KO, and Mct8D1D2KO mice; scale
bars = 10 mm. Cortical MS, MAR, and BFR, n = 4 per genotype.
Figure 8. Bone strength. (a) Representative load displacement
curves from three-point bend testing of P112 WT, Mct8KO, and
Mct8D1D2KO tibias. (b) Yield, maximum and fracture loads, and
stiffness. Data are mean 6 standard error of the mean; n = 4 per
genotype; *P , 0.05 vs WT; analysis of variance followed by
Tukey post hoc test.
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moderate but persistently increased concentration of
circulating T3. Bone turnover and remodeling are reg-
ulated by osteocytes, which orchestrate the balanced
activities of bone-resorbing osteoclasts and bone-forming
osteoblasts (33, 34), both of which express Mct8 (4).
Furthermore, Dio2 has an essential homeostatic role in
osteoblasts to optimize bone formation, mineralization,
and strength (8). Thus, the phenotype of skeletal thyroid
hormone excess in adult Mct8KO mice indicates an
additional thyroid hormone transporter is expressed in
osteocytes and/or osteoclasts and/or osteoblasts.
Taken together, these data demonstrate that MCT8 is
an essential thyroid hormone transporter in growth plate
chondrocytes, but its role in other skeletal cells is less critical.
Role of circulating and local thyroid status in
Mct8D1D2KO mice
Delayed skeletal development in Mct8D1D2KO mice
occurs despite elevated circulating T3 levels throughout
growth. Tissue thyroid hormone deficiency during endo-
chondral ossification, and an absence of local T4 to T3
conversion in the skeleton ofMct8D1D2KO mice, indicate
that Mct8 is a major thyroid hormone transporter during
linear growth. The similar defects in endochondral ossifi-
cation observed in Mct8KO and Mct8D1D2KO mice
(Figs. 2 and 3) further indicate that Mct8 is functionally
indispensable in growth plate chondrocytes. By contrast, the
more severe osteoporotic phenotype in adultMct8D1D2KO
mice (Figs. 4–8) results at least in part from their prolonged
prior exposure to elevatedT3 (Fig. 1) (19), confirming that an
additional transporter can compensate forMct8deficiency in
the regulation of bone mass and strength. Nevertheless,
Mct8D1D2KO mice also have higher systemic T4 concen-
trations at all ages compared withMct8KOmice, suggesting
that the increasedT4 levelsmay contribute to themore severe
skeletal phenotype possibly via nongenomic actions (1).
Increased TSH concentrations in Mct8KO and
Mct8D1D2KO mice
A further consideration is that circulating TSH con-
centrations were increased by twofold to threefold in
Mct8KO mice and by 100-fold in Mct8D1D2KO mice.
Studies in TSH receptor (Tshr) KO mice led to the pro-
posal that TSH acts as a negative regulator of bone
remodeling (35). Although Tshr expression is well
documented in osteoblasts, data from several labora-
tories are contradictory, demonstrating that TSH in-
hibits (35), has no effect on (36–38), or stimulates
(39–41) osteoblast differentiation and activity. Tshr is
also expressed in osteoclasts, and most studies indicate
TSH inhibits osteoclastogenesis and function (35, 37,
41, 42). Overall, the proposal that TSH inhibits bone
turnover and remodeling (35) has been supported by
intervention studies in which intermittent treatment of
ovariectomized rodents with TSH increased bone mass
and strength (43).
In the current studies, however, both Mct8KO and
Mct8D1D2KOmice have elevated circulating TSH levels
but display an osteoporotic phenotype that is more severe
in Mct8D1D2KO mice, in which TSH levels are much
higher. These findings are not consistent with a major
inhibitory role for TSH on bone turnover (35, 42, 43) in
Mct8 mutant mice. Rather, the findings demonstrate the
fundamental importance of local temporal control of
tissue T3 availability and action by thyroid hormone
transporters and Dio2 in bone.
A physiological requirement for thyroid hormone
transport in the skeleton
In conclusion, the current studies demonstrate a key
role for MCT8 in growth plate chondrocytes during
endochondral ossification and postnatal growth. The
more severe bone loss in adult Mct8D1D2KO mice in-
dicates an additional thyroid hormone transporter may
act with MCT8 to regulate bone turnover. Overall, the
studies demonstrate an essential physiological role for
MCT8 in bone. MCT8 is a physiologically important
thyroid hormone transporter in chondrocytes, but it is
likely to act with an additional transporter in other
skeletal cells to regulate the effects of T3 on adult bone
mineralization, mass, and strength.
Table 2. Relationship Between Systemic Thyroid Status and Skeletal Phenotype in Various Mouse Models
Serum Hormones
Juvenile Bone
Development
Adult
ReferenceT4 Level T3 Level Bone Mass Bone Strength
Hypothyroid ↓ ↓ Delayed ↑ ↑ Bassett and Williams (1)
Hyperthyroid ↑ ↑ Advanced ↓ ↓ Bassett and Williams (1)
D2KO ↑ N N ↑ ↑ Bassett et al. (8) and Galton et al. (31)
D1D2KO ↑ N N ↑ ↑ Bassett et al. (8) and Galton et al. (32)
MCT8KO ↓ ↑ Delayed ↓ ↓ Figs. 1–8
MCT8D1D2KO ↑ ↑ Delayed ↓ ↓ Figs. 1–8
Abbreviation: N, normal.
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